NASDAQ:KANG - iKang Healthcare Group Stock Price, News, & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Sign in or create an account to add this stock to your watchlist.
$20.53 0.00 (0.00 %)
(As of 01/18/2019)
Previous Close$20.53
Today's Range$20.52 - $20.55
52-Week Range$15.27 - $21.01
Volume306,806 shs
Average Volume154,054 shs
Market Capitalization$1.43 billion
P/E Ratio89.26
Dividend YieldN/A
Beta-0.13
iKang Healthcare Group, Inc., together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. It operates in two segments, Medical Examinations, and Other Medical Services and Dental Services. The company offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab test, electrocardiogram, ultrasound, and X-ray examination items. It also provides value-added services at various medical centers, such as disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening, and functional medicine testing; dental care comprising oral health, pediatric dentistry, cosmetic dentistry, orthodontics, and dental implants; outpatient services that include acupuncture, Chinese medicine, gynecology, internal medicine, obstetrics, ophthalmology, pediatrics, urology, and minor surgery; and on-site healthcare management or clinical services. The company primarily serves corporate and individual customers through a network of self-owned medical centers and the facilities of third-party service providers. As of July 16, 2018, it had a network of 113 self-owned medical centers in 33 cities of China, which comprise Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu, Fuzhou, Jiangyin, Changzhou, Wuhan, Changsha, Yantai, Yinchuan, Weihai, Weifang, Shenyang, Xi'an, Wuhu, Guiyang, Ningbo, Foshan, Jinan, Bijie, Qingdao, Wuxi, Kaili, Mianyang, and Zhenjiang, as well as Hong Kong; and approximately 400 third-party facilities. The company was formerly known as China iKang Healthcare, Inc. and changed its name to iKang Healthcare Group, Inc. in February 2014. iKang Healthcare Group, Inc. is headquartered in Beijing, the People's Republic of China. As of August 14, 2018, iKang Healthcare Group, Inc. was taken private.

Receive KANG News and Ratings via Email

Sign-up to receive the latest news and ratings for KANG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KANG
CUSIPN/A
Phone86-10-5320-6688

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$563.93 million
Cash Flow$0.8597 per share
Book Value$5.47 per share

Profitability

Net Income$-17,300,000.00

Miscellaneous

EmployeesN/A
Market Cap$1.43 billion
Next Earnings Date3/28/2019 (Estimated)
OptionableOptionable

iKang Healthcare Group (NASDAQ:KANG) Frequently Asked Questions

What is iKang Healthcare Group's stock symbol?

iKang Healthcare Group trades on the NASDAQ under the ticker symbol "KANG."

How were iKang Healthcare Group's earnings last quarter?

iKang Healthcare Group Inc (NASDAQ:KANG) posted its quarterly earnings data on Wednesday, August, 31st. The medical research company reported $0.04 EPS for the quarter. The medical research company had revenue of $101.20 million for the quarter. iKang Healthcare Group had a negative net margin of 2.88% and a positive return on equity of 4.25%. During the same quarter last year, the company earned $0.16 earnings per share. View iKang Healthcare Group's Earnings History.

When is iKang Healthcare Group's next earnings date?

iKang Healthcare Group is scheduled to release their next quarterly earnings announcement on Thursday, March 28th 2019. View Earnings Estimates for iKang Healthcare Group.

Has iKang Healthcare Group been receiving favorable news coverage?

Media stories about KANG stock have been trending neutral on Monday, according to InfoTrie. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. iKang Healthcare Group earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the company's share price in the near term.

Who are some of iKang Healthcare Group's key competitors?

What other stocks do shareholders of iKang Healthcare Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iKang Healthcare Group investors own include Madrigal Pharmaceuticals (MDGL), Depomed (DEPO), Edap Tms (EDAP), Bausch Health Companies (BHC), Novartis (NVS), Catalyst Pharmaceuticals (CPRX), Energy Transfer LP Unit (ET), Allena Pharmaceuticals (ALNA), Amarin (AMRN) and Melinta Therapeutics (MLNT).

Who are iKang Healthcare Group's key executives?

iKang Healthcare Group's management team includes the folowing people:
  • Mr. Ligang Zhang, Chairman, CEO & Pres (Age 47)
  • Mr. Yang Chen, Chief Financial Officer (Age 48)
  • Ms. Faith Feiyan Huang, COO & Director (Age 48)
  • Christy Xie, Director of Investor Relations
  • Mr. Hua Liu, VP of Sales (Age 41)

Who are iKang Healthcare Group's major shareholders?

iKang Healthcare Group's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Hillhouse Capital Advisors Ltd. (4.21%), BlackRock Inc. (1.59%), Alpine Associates Management Inc. (0.75%), Norges Bank (0.55%), City Financial Investment Co Ltd (0.44%) and OMERS ADMINISTRATION Corp (0.39%).

Which institutional investors are selling iKang Healthcare Group stock?

KANG stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Northern Trust Corp, Barclays PLC, California Public Employees Retirement System, OMERS ADMINISTRATION Corp, Bank of America Corp DE, Geode Capital Management LLC and Geode Capital Management LLC.

Which institutional investors are buying iKang Healthcare Group stock?

KANG stock was purchased by a variety of institutional investors in the last quarter, including Hillhouse Capital Advisors Ltd., Alpine Associates Management Inc., Norges Bank, BlackRock Inc., City Financial Investment Co Ltd, S. Muoio & CO. LLC, Athos Capital Ltd and Gabelli Funds LLC.

What is iKang Healthcare Group's stock price today?

One share of KANG stock can currently be purchased for approximately $20.53.

How big of a company is iKang Healthcare Group?

iKang Healthcare Group has a market capitalization of $1.43 billion and generates $563.93 million in revenue each year.

What is iKang Healthcare Group's official website?

The official website for iKang Healthcare Group is http://www.ikang.com.

How can I contact iKang Healthcare Group?

iKang Healthcare Group's mailing address is B-6F SHIMAO TOWER 92A JIANGUO ROAD CHAOYANG DISTRICT, Beijing F4, 100022. The medical research company can be reached via phone at 86-10-5320-6688 or via email at [email protected]


MarketBeat Community Rating for iKang Healthcare Group (NASDAQ KANG)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  142 (Vote Underperform)
Total Votes:  263
MarketBeat's community ratings are surveys of what our community members think about iKang Healthcare Group and other stocks. Vote "Outperform" if you believe KANG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KANG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel